New Delhi: India's Himachal Pradesh High Court has asked the state government to establish a committee of experts in ord...
Singapore: The several bans on Proxyvon, a brand under India-based Wockhardt sold formulation of the painkiller dextropr...
Singapore: Indian pharmaceutical major, Cadila Pharmaceutical is getting closer to constructing a modern manufacturing f...
Singapore: A latest research report filed by Ikon Marketing Consultants revealed that the Indian domestic nutraceutical ...
Singapore: India based Perfint Healthcare, solution provider for image guided interventional procedures in oncology and ...
Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, ...
Singapore: Jubilant Life Sciences, an integrated Pharmaceuticals and Life Sciences Company announced that it has receive...
New Delhi: The US Food and Drug Administration (FDA) has approved Absorica, a novel, patented brand formulation of the a...
Singapore: Novo Nordisk is all set to launch a new basal insulin for adult patients with type 1 and type 2 diabetes, Tre...
India: With a thrust on technology development through public private partnerships, the union budget 2014 offers big enc...
Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...
Government policies are among the major challenges before companies operating in the life sciences sector in the Asia Pa...
Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the...
Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...
Mumbai: Recognizing India as a model for the global vaccine market, the Biotechnology Industry Organization (BIO) has pl...
Pune-based Serum Institute of India (SIIL), one of the largest providers of affordable quality vaccines in the world, ha...
Tokyo: The 7th in-Pharma Japan and 26th Interphex Japan, which are being concurrently held at Tokyo Big Sight, Japan, k...
New Delhi: Ranbaxy Laboratories has reported a 55 percent growth in sales revenue in the second quarter of 2012 over the...
